POMDOCTOR LIMITED Class A (POM)
NASDAQ: POMConsumer DiscretionaryOther Specialty StoresUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
POM stock chart
Technical analysisKey statistics
All statistics- Market cap
- $60.96M
- EPS (TTM)
- -$40.31
- Dividend yield
- None
- 52-week range
- 0.433 – 102.42
- Day range
- 1.54 – 1.70
- Volume / Avg
- 13.87K / 2.05M
- Beta
- —
- Shares outstanding
- 35.76M
52-week range
POM stock today
POMDOCTOR LIMITED (POM) closed at $1.70 on Nov 20, up 5.28% (+$0.085), versus the S&P 500's 3.70% decline. Trading was light, with 13.87K shares changing hands, about 1% of the average daily volume. At this level, POM sits near the bottom of its 52-week range of $0.433 to $102.42: 98.3% below the high and 291.5% above the low.
POMDOCTOR LIMITED has posted a net loss over the last twelve months (EPS of -$40.31), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About POMDOCTOR LIMITED
Company profilePomdoctor Limited, through its subsidiaries, offers an online B2C portal to sell pharmaceutical products. The company develops an online medical services platform for chronic diseases in China. The company focuses on chronic disease management and pharmaceutical services and offers platform for medical services, which connects patients to doctors and pharmaceutical products.
- Sector
- Consumer Discretionary
- Industry
- Other Specialty Stores
- CEO
- Mr. Zhenyang Shi
- Headquarters
- Guangzhou
- Employees
- 165
- IPO year
- 2025
- Website
- 7lk.com
Financial highlights
Full financialsIn fiscal 2025, POMDOCTOR LIMITED generated $57.2 million in revenue. POMDOCTOR LIMITED reported a net loss of $18.7 million. Gross margin was 13.1% and operating margin -29.7%.
| Fiscal year | FY 2025 |
|---|---|
| Revenue | $57.19M |
| Growth | — |
| Net income | $-18.72M |
| EPS (diluted) | $-3.14 |
POM news
All POM news- POMDOCTOR LIMITED Regains Compliance with Nasdaq Bid Price RequirementPR Newswire
- POMDOCTOR LIMITED Announces Receipt of Nasdaq Notifications Regarding Continued Listing RequirementsPR Newswire
- POMDOCTOR LIMITED Highlights the Shift from Reactive Treatment to Predictive HealthcarePR Newswire
- POMDOCTOR LIMITED Announces Receipt of Nasdaq Staff Delisting DeterminationPR Newswire
POMDOCTOR LIMITED peers
Consumer Discretionary sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| RENTRent the Runway Inc. Class A | 1.79 | -3.76% | $60.73M | vs POM |
| SORAAsiaStrategy | 2.17 | -0.46% | $53.95M | vs POM |
| SPWHSportsman's Warehouse Holdings Inc. | 1.22 | 0.00% | $47.75M | vs POM |
| BARKBARK Inc. Class A | 8.75 | -0.34% | $77.98M | vs POM |
| WSHPWeShop Holdings Limited Class A | 1.66 | -5.68% | $40.20M | vs POM |
| PEWGrabAGun Digital Holdings Inc. | 1.27 | -2.31% | $37.58M | vs POM |
| NAASNaaS Technology Inc. ADR | 1.50 | -9.44% | $36.84M | vs POM |
| HTLMHomesToLife Ltd | 0.9445 | -14.90% | $91.79M | vs POM |
Indexes, lists and sector
Largest Consumer Discretionary stocks
POMDOCTOR LIMITED stock FAQ
What is POMDOCTOR LIMITED's stock price today?
POM last traded at $1.70 as of Nov 20, 4:00 PM EST, up 5.28% on the day. Prices are delayed at least 15 minutes.
Does POMDOCTOR LIMITED pay a dividend?
No. POMDOCTOR LIMITED does not currently pay a regular cash dividend.
Who is POMDOCTOR LIMITED's CEO?
Mr. Zhenyang Shi is the chief executive officer of POMDOCTOR LIMITED Class A, which has about 165 employees.
Has POM ever split its stock?
Yes. The most recent POM stock split was a 1-for-3 split on Oct 21, 2026.
What is the POM 52-week high?
The 52-week high for POM is $102.42 and the 52-week low is $0.433. The stock is currently 98.3% below its high.